Vibrio vulnificus Type 6 Secretion System 1 contains anti-Bacterial properties. by Church, SR et al.
RESEARCH ARTICLE
Vibrio vulnificus Type 6 Secretion System 1
Contains Anti-Bacterial Properties
Selina R. Church1, Thomas Lux1, Craig Baker-Austin2, Sam P. Buddington1, Stephen
Ll. Michell1*
1 Biosciences, College of Life and Environmental Sciences, University of Exeter, Exeter, Devon, United
Kingdom, 2 Centre for Environment, Fisheries and Aquaculture Sciences, Weymouth Laboratory,
Weymouth, Dorset, United Kingdom
* S.L.Michell@exeter.ac.uk
Abstract
Vibrio vulnificus is a bacterium responsible for severe gastroenteritis, sepsis and wound
infections. Gastroenteritis and sepsis are commonly associated with the consumption of raw
oysters, whereas wound infection is often associated with the handling of contaminated fish.
Although classical virulence factors of this emerging pathogen are well characterised, there
remains a paucity of knowledge regarding the general biology of this species. To investigate
the presence of previously unreported virulence factors, we applied whole genome sequenc-
ing to a panel of ten V. vulnificus strains with varying virulence potentials. This identified two
novel type 6 secretion systems (T6SSs), systems that are known to have a role in bacterial
virulence and population dynamics. By utilising a range of molecular techniques and assays
we have demonstrated the functionality of one of these T6SSs. Furthermore, we have shown
that this system is subject to thermoregulation and is negatively regulated by increasing salin-
ity concentrations. This secretion system was also shown to be involved in the killing of V. vul-
nificus strains that did not possess this system and a model is proposed as to how this
interaction may contribute to population dynamics within V. vulnificus strains. In addition to
this intra-species killing, this system also contributes to the killing of inter bacterial species
and may have a role in the general composition of Vibrio species in the environment.
Introduction
V. vulnificus is a Gram negative opportunistic pathogen typically isolated frommarine and
coastal environments [1]. The bacterium is capable of causing an array of disease symptoms
such as gastroenteritis, wound infection and primary septicaemia [2]. Wound infection is com-
monly associated with recreational activities in contaminated water or handling of infected fish
and can present with edema, bullae, cellulitis and necrotising fasciitis [2]. In severe cases ampu-
tation of limbs may be required. Unlike wound infections which have on average a 25%mortal-
ity rate, primary septicaemia, which is often associated with the consumption of contaminated
seafood, has a greater than 50%mortality rate rising to 100% without the prompt administra-
tion of antibiotic therapy [1]. Currently, in America, the bacterium is the leading cause of sea-
food related deaths, and due to climate change causing an increase in surface sea temperature,
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the emergence of this pathogen in colder regions such as the Baltic Sea are becoming increas-
ingly common [3].
Although this pathogen is known to be highly pathogenic, the number of severe human
infections reported each year is extremely low given the virulence potential and environmental
prevalence of this bacterium [4]. This has led researchers to believe that not all strains are equal
in virulence,with some strains better adapted to causing human disease than others [5]. How-
ever, a genetic basis for this difference in virulence potential is yet to be established. Further-
more, there is limited knowledge surrounding the general biology of V. vulnificus and to date
only two secretion systems have been characterised in this bacterium, the type 1 secretion sys-
tem (T1SS) and the type 2 secretion system (T2SS) [6]. The former is known to secrete the
well-studied toxin RtxA which has been shown to be required for both gut pathogenesis and
dissemination throughout the body [7], whereas the latter is required for the secretion of the
haemolysin, VvhA [6], a toxin which is also required for gut pathogenesis [7]. To investigate
the presence of previously unreported virulence factors in V. vulnificus, we performedwhole
genome sequencing which led us to identify previously unreportedT6SSs.
The T6SS is found in approximately 25% of all sequencedGram negative bacterial genomes,
and is made up of 13 conservedproteins [8]. These 13 proteins are hypothesised to form a mac-
romolecular structure similar to the contractile tail of bacteriophage [9]. The needle like struc-
ture of the T6SS is composed of Hcp, VrgG and PAAR proteins [10], with ATPase activity
being provided by ClpV and the core scaffolding protein, IcmF [11, 12]. Unlike previously
identified secretion systems, which usually export anti-eukaryotic effectors, the T6SS has dual
functions, secreting both anti-eukaryotic and anti-prokaryotic effectors [13]. The latter func-
tion in particular has captured the attention of many researchers, as it poses the potential for
development of novel antimicrobials [14]. In addition to secreting anti-bacterial toxins, it has
also been shown that anti-bacterial T6SS encoding bacteria also harbour immunity proteins.
These immunity proteins are able to neutralise the deleterious effects of toxins to prevent self-
intoxication and provide immunity betweenT6SS harbouring sister cells [14, 15].
To study the role of the T6SS in affecting the population dynamics of Vibrio spp. this study
employed co-culturing assays. These assays demonstrated that the T6SS present inV. vulnificus
can play an important role in bacterial population composition through anti-bacterial activity.
Furthermore, we present a hypothesis describing how the T6SS may provide an explanation for
the limited number of serious human infections attributed to V. vulnificus given the high abun-
dance of this bacterium in the environment.
Results
V. vulnificus strains vary in their T6SS genetic architecture
In an approach to identify genetic differences betweenV. vulnificus isolates that may account for
species specific phenotypes, whole genome sequencingwas applied to a panel of ten strains of vary-
ing virulencepotential and isolation source (Table 1) [5]. Analysis of this data identified a novel
T6SS, herein referred to as T6SS2, whichwas present in all ten sequenced isolates (S1 Fig). Further-
more, an additional T6SS, present in three out of the ten isolates, T6SS1, was also identified (S2
Fig). This T6SS1 exhibited synteny with the previously characterisedT6SS fromV. cholerae [16]
having 76% similarity over 19.2 kb. However, several differences betweenT6SS1 of V. vulnificus
and the T6SS of V. cholerae exist and are depicted in Fig 1. For example, V. cholerae (Fig 1A) con-
tains two hcp genes, which are distributed across chromosomes 1 and 2 whereas the sole hcp gene
ofV. vulnificus T6SS1 is located within the T6SS operon on chromosome 2 (Fig 1B). Both T6SS1
and T6SS2 of V. vulnificus contain the 13 core genes required for a functional T6SS (Fig 1B) [8].
However, T6SS2 contains several accessory genes, encoding for a phosphatase and kinase, which
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are absent from T6SS1. Bioinformatic investigation of threeV. vulnificus reference genomes,
YJ016,MO6-24/O and CMCP6 revealed that all three genomes did not contain T6SS1 but all had
T6SS2, although the latter were not annotated as such in their Genbank depositions (S1 Fig).
V. vulnificus T6SS1 secretes Hcp-1 in a temperature and salinity
dependent manner
As T6SS1 of V. vulnificus exhibits synteny with the previously describedT6SS of V. cholerae,
we first sought to demonstrate that T6SS1 was functional in V. vulnificus. This was assessed by
confirming secretion of Hcp-1, a prototypical T6SS secreted component. Western blot analysis
using an antibody against the Hcp peptide sequence; AGTSGSDDWRKPIEA [17] confirmed
that Hcp-1 was secreted into the culture filtrate (Fig 2A). We were able to use the anti- Hcp-1
antibody raised against Hcp-1 from V. cholerae due to the high level of homology betweenV.
cholerae and V. vulnificus (Fig 2B). Previous characterisation of T6SSs from V. cholerae and V.
parahaemolyticus has demonstrated that salinity and temperature can affect activation of these
systems [18, 19]. We therefore investigated the effect of temperature and salinity on T6SS1 of
V. vulnificus in order to determine whether it was similarly regulated.
TheWestern blot using the anti- Hcp-1 antibody shown in Fig 3 demonstrates that Hcp-1 is
secreted at 23°C and 30°C (lanes 2 and 6), temperatures similar to those seen in marine envi-
ronments but not at 37°C (lane 10). When V. vulnificus was cultured at these temperatures in
the presence of 3% w/v NaCl, a similar pattern of secretionwas observedbut at lower levels (cf;
Table 1. Bacterial strains.
Bacterial strains Description Virulence Grouping a Source
V. vulnificus 106-2A Wild-type strain, environmental isolate, T6SS1+ T6SS2+ 3 CEFAS
V. vulnificus 99–743 Environmental isolate, T6SS1- T6SS2+ 3 CEFAS
V. vulnificus MO6-24/O Clinical isolate, T6SS1- T6SS2+ 4 CEFAS
V. vulnificus 99–796 Environmental isolate, T6SS1+ T6SS2+ 4 CEFAS
V. vulnificus ORL-1506 Clinical isolate, T6SS1- T6SS2+ 5 CEFAS
V. vulnificus NSV-5830 Clinical isolate, T6SS1- T6SS2+ 5 CEFAS
V. vulnificus DAL-79087 Clinical isolate, T6SS1- T6SS2+ 3 CEFAS
V. vulnificus DAL-79040 Clinical isolate, T6SS1- T6SS2+ 2 CEFAS
V. vulnificus S3-16 Environmental isolate, T6SS1+ T6SS2+ 1 CEFAS
V. vulnificus S2-22 Environmental isolate, T6SS1- T6SS2+ 3 CEFAS
V. vulnificus ATL-9824 Clinical isolate, T6SS1- T6SS2+ 2 CEFAS
V. fluvialis NCTC 11327 Clinical isolate N/A CEFAS
V. vulnificus SRC1 106-2A ΔicmF1 in-frame, T6SS1- T6SS2+ N/A This study
V. vulnificus SRC2 106-2A ΔicmF2 in-frame, T6SS1+ T6SS2- N/A This study
V. vulnificus 106-2A pSCrhaB3 Wild-type strain containing pSCrhaB3 (Tpr) N/A This study
V. vulnificus 106-2A:icmF1 pSCrhaB3 106-2A ΔicmF1 containing pSCrhaB3 (Tpr) N/A This study
V. vulnificus 106-2A:icmF2 pSCrhaB3 106-2A ΔicmF2 containing pSCrhaB3 (Tpr) N/A This study
V. vulnificus 99–743 pBHR4-groS-RFP V. vulnificus 99–743 containing pBHR4-groS-RFP (Cmr) N/A This study
V. fluvialis NCTC 11327 pBHR-4groS-RFP V. fluvialis NCTC 11327 containing pBHR4-groS-RFP (Cmr) N/A This study
V. vulnificus MO6-24/O pBHR-4groS-RFP V. vulnificus MO6-24/O containing pBHR4-groS-RFP (Cmr) N/A This study
V. cholerae V52 Wild-type strain (Smr) N/A Dr. S. Pukatizki
Escherichia coli DH5α Cloning host N/A Lab stock
Escherichia coli S17 λpir Cloning host and donor strain N/A Lab Stock
Escherichia coli TOP10 Cloning host N/A Invitrogen
a Virulence grouping was determined from the in vivo study performed by Thiaville et al., 2011, virulence increases with numerical value.
doi:10.1371/journal.pone.0165500.t001
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lanes 4, 8 and 12). Qualitative analysis of the cell lysates of these experiments demonstrated
that Hcp-1 was expressed under all conditions but with secretion by the T6SS1 reduced by high
temperature and increased salinity.
V. vulnificus utilises T6SS1 in intra-species killing
The T6SS of V. parahaemolyticus is active against other bacteria at marine like temperatures
[18]. Therefore, we hypothesised that T6SS1 of V. vulnificusmay be similarly involved in bacte-
rial killing as this system is also functional under the same conditions observed forV.
Fig 1. T6SSs of Vibrio vulnificus. (A) Schematic diagram showing the genetic organisation of T6SS of V. cholerae. (B) Schematic representation of the
genetic organisation of T6SSs from V. vulnificus. Accessory proteins present in T6SS2 and absent from T6SS1 are shown in black. Homologous genes
between the two species have been colour matched to represent their similarity.
doi:10.1371/journal.pone.0165500.g001
Fig 2. T6SS1 of V. vulnificus is functional. (A) Western blot employing an antibody against Hcp-1 from V. cholerae demonstrating the presence of Hcp-
1 in the culture filtrate and cell pellet of V. vulnificus 106-2A (lane 1 and 2). Lane 3, protein extract from V. cholerae V52 used as a positive control to
confirm the specificity of the antibody (14 μg of protein per lane). (B) Amino acid alignment of Hcp-1 from V. cholerae and V. vulnificus. Amino acid
differences are boxed in black and epitope to which the anti-Hcp-1 antibody was raised is highlighted in red.
doi:10.1371/journal.pone.0165500.g002
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parahaemolyticus [18]. To test this hypothesis we first sought to determinewhether aV. vulnificus
T6SS1 positive strain could kill aV. vulnificus T6SS1 negative strain, based on the rationale that the
latter strain would be deficient in immunity proteins to T6SS1 effectors. This was investigated by
performing co-culture assays at 30°C using a naturally occurringT6SS1 negativeV. vulnificus envi-
ronmental strain, (99–743) as prey and, a T6SS1 positive environmental strain, (106-2A) as the
attacker. These strains were chosen as 106-2A contains both T6SS1 and T6SS2, whereas 99–743 is
a naturally occurringT6SS1mutant. To test whether T6SS1 conferred a competitive advantage in
106-2A, an in-frame deletion of icmF1, (a gene encoding a core scaffolding protein of the T6SS)
was created in strain 106-2A, resulting in strain SRC1. This mutation was confirmedby whole
genome sequencing (S3 Fig). To confirm that this mutation resulted in an inactive T6SS1,Western
blot analysis was performed to observe secretion of Hcp-1. As can be seen in Fig 4A, SRC1 was
unable to secreteHcp to the culture filtrate at 30°Cwhen compared to the wild type strain. Further-
more, for enumeration purposes the competitive assay was performedusing the prey strain, 99–
743 which has been engineered to be chloramphenicol resistant and the attacker strains, 106-2A,
SRC1 to be trimethoprim resistant. In addition to SRC1, an in-frame icmF2mutant was generated
in T6SS2 (SRC2) to determinewhether T6SS2 played a role in bacterial targeting.
The competitive assays demonstrated that strain 106-2A could indeed target 99–743 at 30°C,
resulting in a significant reduction in numbers of the prey strain (Fig 4B). In contrast to the
observed inhibition of growth of the prey strain 99–743 when co-culturedwith wild-type 106-
2A, co-culture of 99–743 with SRC1 resulted in a significant increase in the competitive index of
the prey strain (Fig 4B). Furthermore, we demonstrated that T6SS2 of 106-2A did not inhibit 99–
743 as evidencedby co-culture with an icmF2 in-frame deletionmutant of 106-2A (SRC2). This
latter experiment resulted in a phenotype comparable to that of the wild-type strain, Fig 4B.
As the prey strain 99–743 is an environmental isolate, we sought to determine whether
T6SS1 of 106-2A could target a hyper-virulent clinical isolate. In order to test this hypothesis
the hyper-virulent reference strain, MO6-24/O which was isolated from a patient with septicae-
mia [20] was selected as a prey strain for use in the co-culture assays. These co-culture assays
demonstrated that as was the case for 99–743, the hyper-virulent clinical strain MO6-24/O was
inhibited by the environmental strain 106-2A in a T6SS1 dependentmanner, as evidenced by a
lack of killing by SRC1 (the icmF1mutant strain) Fig 4C.
V. vulnificus utilises T6SS1 in inter-species killing
T6SSs of several bacteria have been shown to play a role in effectingmicrobial population
dynamics through inter-species killing [21]. In addition, it is known that several pathogenic
Fig 3. Hcp-1 expression from T6SS1 of V. vulnificus 106-2A is dependent upon temperature and salinity. Western blot of cell lysates and
supernatants from V. vulnificus 106-2A cultures grown at 23˚C, 30˚C and 37˚C, using anti-Hcp-1 antibody. Cultures were grown in LB or LB supplemented
with 3% NaCl w/v (SLB) (14 μg of protein per lane).
doi:10.1371/journal.pone.0165500.g003
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Vibrio species exist alongsideV. vulnificus within marine environments and bivalve molluscs
[22]. We hypothesised that the T6SS1 of V. vulnificusmay, in addition to the intra-species kill-
ing demonstrated above, play a role in effecting its proximal marine microflora through inter-
species killing by T6SS1. We selectedVibrio fluvialis as a model bacterium to test this hypothe-
sis as V. fluvialis, along with V. vulnificus, is known to be a shellfish-associated bacterium [23].
Furthermore, these strains were employed as post co- culture enumeration was performed on
TCBS agar, on whichV. vulnificus 106-2A forms green colonies and V. fluvialis forms yellow
colonies. TCBS enumeration plates were incubated at 37°C, at which temperature T6SS1 did
not secrete Hcp-1 (Fig 3, lane 10), excluding the possibility that killing due to T6SS1 was occur-
ring on the enumeration plates.
Fig 4. T6SS1 targets T6SS1 deficient strains of V. vulnificus (A) Western blot employing an antibody against Hcp-1 demonstrating the presence of
Hcp-1 in the supernatant and cell pellet of V. vulnificus 106-2A wild-type. Whereas, Hcp-1 is only detected in the cell pellet of the icmF1 mutant, SRC1 and
not in the supernatant. (B) Competitive index of V. vulnificus 99–743 (prey) following co-culture for two hours with V. vulnificus 106-2A (attacker)
demonstrating an increase in the survival of the naturally occurring T6SS1 negative prey strain, 99–743 when co-cultured with SRC1 compared to 106-2A
wild-type. (C) Competitive index of V. vulnificus MO6-24/O (prey) following co-culture for two hours with V. vulnificus 106-2A (attacker). Competitive index
was calculated using the following equation: (input attacker/input prey)/(output attacker/output prey). Statistical analysis was performed using the
Wilcoxon signed-rank test on log-transformed data. *** = p < 0.0005.
doi:10.1371/journal.pone.0165500.g004
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Unlike the previous intra-species assays, the competitive index could not be calculated for
eitherV. fluvialis or V. vulnificus. This is due to the complete removal of V. fluvialis and V. vul-
nificus in several of the assays resulting in an enumeration count of zero. Therefore, the num-
ber of recovered cells following co-culture is presented in place of the competitive index value.
In co-culture assays whereV. fluvialisNCTC 11327 was used as a prey strain, and the
T6SS1 mutant of V. vulnificus (SRC1) as the attacker, it was observed that V. fluvialis exhibited
a significant increase in growth compared to when co-culturedwith wild-typeV. vulnificus at
30°C (Fig 5A, hatched bars). This suggests that the T6SS1 of V. vulnificus is involved in the
inter-species killing of V. fluvialus. Furthermore, this observedphenotype is unlikely to be
attributable to the T6SS2 of V. vulnificus, as there was no significant difference in the survival
Fig 5. V. vulnificus utilises T6SS1 for inter-species targeting at 30˚C. (A) The CFU/ml of recovered bacteria was recorded following a co-culture T6SS
killing assay at 30˚C for 5 hours when T6SS1 is active in the attacker strain. Attacker strain V. vulnificus 106-2A (solid bars) Prey strain V. fluvialis
NCTC11327 (hatched bars). Co culture enumeration was performed at 37˚C on TCBS where the T6SS is not active in the attacker strain. Statistical
analysis was performed using a 1-way paired Student’s t-test, ** = p < 0.005. (B) Recovered CFU/ml of bacteria following co-culture at 30˚C and
enumeration at 37˚C using antibiotic resistant strains on antibiotic plates. Hatched bars represent the prey strain, V. fluvialis NCTC11327. Solid bars
represent V.vulnificus attacker strains. Statistics were performed using the 2-way unpaired Student’s t-test *** = p < 0.005. (C) Schematic diagram of the
V. fluvialis T6SS gene cluster and distally encoded T6SS associated genes.
doi:10.1371/journal.pone.0165500.g005
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of V. fluvialiswhen co-culturedwith the T6SS2 mutant (SRC2) compared to when co-cultured
with wild-typeV. vulnificus (Fig 5A, hatched bars).
However, it was also observed that whenV. fluvialiswas co-culturedwith the T6SS1 mutant
of V. vulnificus (SRC1), this latter strain appeared to become a prey strain for V. fluvialis as evi-
denced by a complete lack of growth of SRC1 (Fig 5A, solid black bars). Therefore, we reasoned
that this observed inhibition of SRC1 growth may be attributable to a T6SS present in V. fluvia-
lis which is active during enumeration at 37°C. To test this hypothesis, we generated antibiotic
resistant V. vulnificus and V. fluvialis strains allowing for the prey and attacker strains to be
enumerated on separate antibiotic plates. This approach removed the ability for intra-strain
targeting to occur during enumeration at 37°C. Enumeration of a subsequent co-culture assay
on antibiotic containing enumeration plates revealed that there was no inhibition of SRC1 (Fig
5B, solid black bar), suggesting that V. fluvialismay indeed be targeting SRC1 at 37°C on TCBS
agar. This experiment also revealed that during the co-culture at 30°C,V. vulnificus can target
V. fluvialis in a T6SS1 dependent manner as evidencedby an increase in growth of V. fluvialis
when co-culturedwith the SRC1 compared to wild-type and SRC2 (Fig 5B, hatched bar).
Identification of a T6SS in V. fluvialis NCTC 11327
To determinewhetherV. fluvialis contained a T6SS, whichmay be contributing to the observed
targeting of SRC1, whole genome sequencing of V. fluvialisNCTC 11327 was employed. This
approach, coupled with genome annotation, did identify a putative T6SS in V. fluvialis, Fig 5C.
This system contains all of the 13 conserved genes required for a functional T6SS and is similar
in gene organisation to T6SS1 of V. vulnificus. However, unlikeV. vulnificus, V. fluvialis
encodes two hcp genes, which are located distally from the large T6SS operon. This localisation
of hcp genes is similar to that seen in V. cholerae [24]. Furthermore,V. fluvialis also possesses
distally encoded vgrG genes, as well as a homologue of the recently identifiedT6SS adapter pro-
tein-1 (tap-1) (Fig 5C) [25].
The T6SSs in V. vulnificus 106-2A are not virulent towards Galleria
mellonella
To further support our hypothesis that the T6SS1 of V. vulnificus is predominantly involved in
anti-bacterial killing rather than anti-eukaryotic targeting, we investigated the role of T6SS1 in
a Galleria melonella infectionmodel. Groups of 10 larvae were injectedwith either, V. vulnifi-
cus 106-2A wild-type, SRC1 or SRC2 at 105 cells in the upper most pro-leg and monitored for
signs of disease. The results however demonstrated that both SRC1 and SRC2 were as virulent
compared to the wild-type strain, Fig 6, indicating that neither T6SS1 nor T6SS2 is required by
V. vulnificus for virulence in this infectionmodel, further supporting our hypothesis that the
T6SS1 of V. vulnificus is involved in modulating the composition of environmental bacterial
populations.
Discussion
Although T6SSs have been characterised in many Vibrio species, this is the first report, to our
knowledge, of a functional T6SS in V. vulnificus. Our study has shown a variation in the num-
ber of T6SSs present in ten differentV. vulnificus isolates, with some having two T6SSs and
others only one. This in contrast to V. cholerae, where numerous strains have been shown to
possess just one conservedT6SS [26]. All V. vulnificus strains studied contained the T6SS,
T6SS2 with a subset of strains containing an additional T6SS, T6SS1. Bioinformatic analysis of
both T6SSs of V. vulnificus demonstrated that these systems contained the full repertoire of
genes required for a functional secretion system [8]. V. vulnificus T6SS2 contained accessory
Vibrio vulnificus Type 6 Secretion System
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genes encoding for proteins such as a phosphatase and kinase, which have previously been
shown to be required for T6SS regulation in P. aeruginosa [27]. Although the accessory pro-
teins observed in T6SS2 were not observed in T6SS1, T6SS1 does contain vasH. This gene
encodes for an alternative sigma54 factor, which has previously been shown to be involved in
initiation of transcription of the T6SS in V. cholerae [28, 29] and as such may have a regulatory
role in the transcription of T6SS1 in V. vulnificus.
T6SS1 of V. vulnificus exhibits considerable overall synteny with the T6SS of V. cholerae
[30]. However, the most notable differences between the T6SSs of these bacteria are predomi-
nantly associated with the hcp and vgrG genes. For example, V. cholerae contains two hcp and
three vgrG genes, in contrast to the apparent presence of only one copy of each in theV. vulnifi-
cus T6SSs. VgrGs play a structural role in the formation of the T6SS, however several vgrGs
have also been shown to encode for effector functions, such as those identified in V. cholerae,
and as such are denoted as evolved VgrGs [17, 24]. Evolved vgrGs are distinguishable from
structural vgrGs based on the presence of a C-terminal extension. The vgrG genes in T6SS1 and
T6SS2 of V. vulnificus appear not to be evolved vgrG genes due to the lack of a C-terminal
extension.
In this paper we show for the first time that T6SS1 of V. vulnificus is functional. Expression
and secretion of Hcp-1 was shown to be affected by both temperature and salinity as has been
observedpreviously in bothV. cholerae and V. parahaemolyticus [18, 19]. Our initial findings
demonstrated that the temperature regulation of V. vulnificusHcp-1 was identical to those of
Hcp-2 in V. parahaemolyticus [18]. In contrast to this temperature dependent similarity, salin-
ity appeared to have a differential effect on secretion of V. vulnificusHcp-1 relative to V.
Fig 6. The T6SSs of V. vulnificus do not contribute towards virulence in the infection model, Galleria mellonella. V. vulnificus is virulent
in the infection model G. mellonella, however neither the icmF T6SS1 mutant, SRC1 nor the icmF T6SS2 mutant, SRC2 are attenuated in G.
mellonella. Phosphate buffered saline (PBS) was used as a negative control demonstrating 100% survival. Experiments were performed three
times in triplicate where n = 10 and statistics performed using GraphPad Prism version 5 using the Log-rank (Mantel-Cox) test.
doi:10.1371/journal.pone.0165500.g006
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parahaemolyticus Hcp-2 [18]. Differential regulation of T6SSs in other Vibrio species is not
uncommon, as V. cholerae V52 Hcp has been shown to be secreted at 37°C but Hcp of the O1
V. cholerae strain, A1552, is secreted at only 23°C [19, 30]. Our observation that Hcp-1 is not
secreted at 37°C suggests that the function of V. vulnificus T6SS1 is unlikely to be associated
with an anti-eukaryotic phenotype. A hypothesis supported by our observation that SRC1 dis-
plays the same virulence in a G.mellonellamodel of infection to that of the wild-type.
Based on T6SS1’s temperature regulation and similarity with the anti-bacterial T6SS of V.
cholerae, [21] we hypothesised that V. vulnificus T6SS1 may exhibit anti-bacterial properties.
Furthermore, our observation that only some strains of V. vulnificus contain this additional
T6SS1 led us to propose that this systemmay convey a competitive advantage. Through the use
of co-culturing assays this hypothesis was supported by the observation that T6SS1 positive
strains do have a competitive advantage over those that are T6SS1 negative. Furthermore,
mutagenesis studies demonstrated that this phenotype was attributed to T6SS1 and not T6SS2.
Given the observed antagonistic role of V. vulnificus T6SS1, it is tempting to speculate on
this system’s role in the natural environment, and potentially more widely in terms of clinical
impact. Taken together, we hypothesise that the limited number of seriousV. vulnificus human
infections compared with the high abundance of this pathogen [4] may be attributable to
T6SS1 dependent killing of certain hyper virulentV. vulnificus strains. This hypothesis is based
on data in this study which has shown that a lesser virulentV. vulnificus strain can target a
hyper virulent strain in a T6SS1 dependent manner, leading us to suggest that the same sce-
nario may also occur naturally in the environment. This proposed scenario would potentially
lead to a decrease in the number of hyper virulent strains in the environment, whichmay lessen
the chances of humans being exposed to hyper virulent strains, and as such only a limited num-
ber of serious cases reported each year. This scenario is appealing as our study identified a pre-
dominance of T6SS1 among lesser virulent environmental strains [5]. In accordance with our
hypothesis, other researchers have also suggested that the main role of the T6SS is to attack
competing cells and enhance the fitness of the secreting cell in poly-microbial communities
[14, 31]. However, it should be noted that although this study identified a predominance of
T6SS1 among lesser virulent strains, T6SS1 was also identified in a hyper virulent environmen-
tal strain, 99–796. Furthermore, given the increase in knowledge regarding different effector/
immunity proteins in V. cholerae allowing for differing strains of V. cholerae to outcompete
each other based on their effector repertoire [26] this hypothesis may be too simplistic. Initial
in silico investigations into the V. vulnificus T6SS1 and T6SS2 effectors has demonstrated that
V. vulnificus contains mainly rhs effectors with DNase activity. However, to fully answer our
proposed hypothesis the identification of V. vulnificus T6SS1 and T6SS2 effectors and immu-
nity proteins needs to be elucidated, a study which our laboratory is currently undertaking.
As well as intra-species targeting, bacterial species such as V. cholerae and S.marcescens uti-
lise their T6SS for inter-species targeting [21, 32]. Therefore, we sought to determine whether
V. vulnificus T6SS1 could target other bacterial species. To test this hypothesis, co-culture
assays were performed using the prey strain,V. fluvialisNCTC 11327. Both the anti-bacterial
properties of T6SS1 and T6SS2 were investigated as it was hypothesised that T6SS1 may be spe-
cific to intra-species targeting and T6SS2 inter-species targeting. However, the results demon-
strated that T6SS2 played no role in inter-species targeting. The finding that T6SS2 plays no
role in anti-bacterial killing is not unusual as bacteria containing multiple T6SSs can often uti-
lise these system for distinct roles. For example, although B. thailandensis contains a total of
five T6SS, only T6SS-1 has been shown to be anti-bacterial, while T6SS-5 has been shown to
possess an anti-eukaryotic phenotype [33]. Although our studies did not demonstrate any role
for V. vulnificus T6SS2, it is likely that this system is tightly regulated. This hypothesis is based
on the finding that T6SS2 contains the accessory proteins, phosphatase and kinases, two
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proteins which have been shown to be involved with tight regulation of the T6SS, HSI-I in P.
aeruginosa [27].
During co-enumeration on TCBS agar, the V. vulnificus T6SS1 mutant, SRC1 was unable to
survive in the presence of V. fluvialisNCTC 11327 at 37°C. Suggesting that V. vulnificus requires
T6SS1 for survival in mixed bacterial populations. Based on these findings,WGS and annotation
was performed to determinewhetherV. fluvialisNCTC 11327 contained a T6SS whichmay
account for the antagonistic manner of this strain. These investigations identified the presence of
a T6SS locus inV. fluvialisNCTC 11327. Although the functionality of this system was not inves-
tigated, the T6SS locus contains all of the 13 genes required for a functional T6SS [8] and is simi-
lar in gene organisation to the T6SS of V. cholerae V52 [24]. Similarly, a recent bioinformatic
study using theV. fluvialis strain, 85003 also identified the presence of a T6SS cluster, suggesting
that the T6SS is common among V. fluvialis strains [34]. The widespread identification of the
T6SS in theVibrio family is not surprising as many Vibrio spp inhabit similar niches, therefore
containing a mechanism such as the T6SS which can displace competing bacteria when resources
such as space and nutrients are limited would be beneficial [14].
In addition to environmental attacks, a recent publication demonstrated the antagonistic
behavior of the T6SS in vivo [31]. The authors extrapolated this information to suggest the piv-
otal role played by the T6SS in affecting the composition of many poly-microbial communities
and the effects of this system on health and disease outcomes [31]. Similarly, we hypothesise
that the T6SS may play an important role in determining the severity of V. vulnificus disease.
For example, V. vulnificus and V. fluvialis share the oyster as a common niche and human infec-
tion route [4, 23] and in this study we have demonstrated that at 37°C in the absence of T6SS1,
V. fluvialis can targetV. vulnificus. Furthermore, we have identified that the majority of V. vulni-
ficus strains are T6SS1 negative. Therefore, we propose that upon human ingestion of an oyster
containingV. fluvialis and T6SS1 negativeV. vulnificus cells,V. fluvialismay target and remove
V. vulnificus. In comparison to V. vulnificuswhich can exhibit varying degrees of pathogenicity
[5],V. fluvilais is commonly associatedwith mild gastroenteritis [23]. Therefore, we speculate
that in this instance,V. fluvialis could acts as a “probiotic”, by targeting and removing hyper viru-
lent V. vulnificus cells, leaving only the lesser virulentV. fluvialis for the host’s immune system to
eliminate. Based on this hypothesis, it is tempting to conclude that only a limited number of seri-
ousV. vulnificus infections would be reported each year. Further work is required to understand
whether the removal of V. vulnificus by V. fluvialis is due to theV. fluvialisT6SS or whether there
are potentially other diffusible anti-microbial molecules secreted by V. fluvilais. This is based on
the finding that V. fluvilaiswas able to targetV. vulnificus on enumeration plates where colonies
were sufficiently diluted to not be in contact. It is highly likely that V. fluvialismay secrete diffus-
ible anti-microbial molecules as otherVibrios have previously been shown to secrete anti-micro-
bial molecules other than those associatedwith the T6SS [35].
In conclusion, this study has identified for the first time two T6SSs in V. vulnificus. Further-
more, we have identified the conditions under which T6SS1 is active, and demonstrated that
T6SS1 contains anti-bacterial properties. These findings have been used to hypothesise how V.
vulnificus T6SS1 may be used to shape Vibrio microbial populations and how inter-bacterial
interactionsmay explain the limited number of serious human infections attributed to V. vulni-
ficus given the natural prevalence and virulence potential of this bacterium.
Materials and Methods
Bacterial strains, plasmids and culture conditions
V. vulnificus strains and V. fluvialisNCTC 11327, were routinely cultured at 30°C and V. choer-
lae V52 at 37°C in Luria-Bertani (LB) broth (Oxoid) unless otherwise stated. Where
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appropriate, antibiotics (Sigma) were added at the following concentrations; ampicillin (Amp)
100 μg/ml, Kanamycin (Km) 50 μg/ml, chloramphenicol (Cm) 35 μg/ml for Escherichia coli
and 10 μg/ml for Vibrio vulnificus, Streptomycin 100 μg/ml and Trimethoprim (Tp) 100 μg/
ml. Strains, plasmids and primers used in this study are listed in Tables 1, 2 and 3.
Identification of putative T6SS(s) in V. vulnificus 106-2A
WGS of V. vulnificus isolates was carried out by the Exeter Sequencing Service,University of
Exeter, Exeter, UK.De-novo assembly of raw reads was performed using the A5-piepeline [36]
followed by annotation of contigs using the RAST server [37]. Mapping of the putative T6SS
clusters identified using RAST were performed using CloneManager Professional Suite 8.
Prior to GenBank submission assembled scaffolds were screened for contaminants against the
UniVec database. Genomic features were predicted and annotated using prokka software and
after manual curation submitted through the NCBI wgs portal. The genomes are accessible
through the NCBI database with the following accession numbers:Vibrio vulnificus S2-22
Table 2. Plasmids.
Plasmids Description Source
pDM4 Suicide vector (Cmr, R6K origin, sacBR) Milton, et al 1996
pGEM®-T Easy High copy number cloning vector (Ampr) Promega
pRK2013 Conjugation, helper strain (Kmr) Lab stock
pSCrhaB3 Vector containing Tpr cassette Dr. C. Hemsley
pBHR4-groS-RFP Vector containing Cmr cassette Dr. C. Hemsley
pSRC6a pGEM®-T Easy containing 106-2A icmF2 left flanking region This Study
pSRC7a pGEM®-T Easy containing 106-2A icmF2 right flanking region This Study
pSRC8a pGEM®-T Easy containing 106-2A icmF1 left flanking region This Study
pSRC9b pGEM®-T Easy containing 106-2A icmF1 right flanking region This Study
pSRC10 pDM4 containing containing NdeI ligated106-2A icmF2 left flank and right flank This Study
pSRC11 pDM4 containing containing NdeI ligated106-2A icmF1 left flank and right flank This Study
doi:10.1371/journal.pone.0165500.t002
Table 3. Primer sequences.
Primer Name Description Primer Sequence 5’–3’
M13 Forward Sequencing primer TGTAAAACGACGGCCAGT
M13 Reverse Sequencing primer CAGGAAACAGCTATGAC
LFF 106-2A icmF1 SmaI 106-2A left flanking region IcmF forward TGCCCGGGAGTGATTGGTCTGAGGCCATTG
LFR 106-2A icmF1 NdeI 106-2A left flanking region IcmF reverse TGCATATGTATCGGGTCTTGACGTAACTGG
RFF 106-2A icmF1 NdeI 106-2A right flanking region IcmF forward TGCATATGTGGGCATTCTTTCGATTGTTAG
RFR 106-2A icmF1 ApaI 106-2A right flanking region IcmF reverse TTGGGCCCCTCGGCACGATAAAGCTCTCTC
LFF 106-2A icmF2 SmaI 106-2A right flanking region IcmF2 forward TGCCCGGGACCAGAGTGCGGATTATATTTC
LFR 106-2A icmF2 NdeI 106-2A left flanking region IcmF2 reverse TGCATATGAATAACCAACAAACGGTTAAAG
RFF 106-2A icmF2 NdeI 106-2A right flanking region IcmF2 forward TACATATGGCAAGGCCGCAATCTCGCAAAG
RFR 106-2A I icmF2 ApaI 106-2A right flanking region IcmF2 reverse TCGGGCCCTGCCAATTTGAGGTAAACCATC
CmpDM4_F first crossover integrant primer forward ATGGAGAAAAAAATCACTGGATATACCACC
CmpDM4_R first crossover integrant primer reverse TTACGCCCCGCCCTGCCACTCATCGCAGTA
LFF_ icmF1_MutScr Second cross over confirmation primer GGCGGAAAGTGGAACAAAGC
RFR_ icmF1_MutScr Second cross over confirmation primer TACTCGGTTTGCTGGTACTC
LFF_ icmF2_MutScr Second cross over confirmation primer CGGCTGTGTTAGTCAGTGTG
RFR_ icmF2_MutScr Second cross over confirmation primer CTCATTCGATCACCGTTACC
doi:10.1371/journal.pone.0165500.t003
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(LKUU00000000);Vibrio vulnificus 106-2A (LMTD00000000);Vibrio vulnificusORL-1506
(LMXV00000000);Vibrio vulnificusNSV-5830 (LMXW00000000);Vibrio vulnificus 99–796
(LMXX00000000);Vibrio vulnificus 99–743 (LMXY00000000);Vibrio vulnificusDAL-79087
(LMXZ00000000);Vibrio vulnificusDAL-79040 (LMYA00000000); Vibrio vulnificus
ATL-9824 (LMYB00000000);Vibrio vulnificus S3-16 (LMTC00000000);Vibrio fluvialis
NCTC11327 (LMTE00000000).
Generation of V. vulnificus SRC1 and SRC2 mutants
SRC1 and SRC2 mutants of V. vulnificus 106-2A were produced using pDM4 [38]. Flanking
regions upstream and downstream of the target gene were PCR amplified using the primers
described in Table 3. Correctly sequenced flanking regions were digested, purified and ligated
into pDM4, resulting in pSRC10 and pSRC11, described in Table 2. pSRC10 and pSRC11 were
subsequently transformed into E.coliDH5α and chromosomally introduced to V. vulnificus
106-2A using the conjugal donor pRK2013 and plated onto CholeraMedium TCBS (Oxoid)
supplemented with choloramphenicol at 10 μg/ml. Meridiploid strains were confirmed using
LFF or RFR flanking primers with cmpDM4_F or cmpDM4_R primers. Chromosomally con-
firmed first cross-over integrants were then plated onto LB supplemented with 10% sucrose
(Sigma) incubated at 24°C to exercise the plasmid in a second cross-over event replacing the
wildtype gene with the mutated gene. Mutants were confirmed using MutScr primers detailed
in Table 3, DNA sequencing andWGS.
Generation of antibiotic resistant Vibrio strains
Antibiotic resistant strains were generated using tri-parental conjugal mating using the helper
strain pRK2013 and plated onto TCBS agar containing appropriate antibiotic.
Hcp secretion analysis
OvernightV. vulnificus cultures were back-diluted to an OD590 0.03 in 25 ml volumes and
grown to mid-log OD590 1.5. Cellular fractions were normalised to OD590 1 in 1ml LB, centri-
fuged at 2000 rpm for 3 min, supernatant removed and pellets re-suspended in 50 μl bug
buster, 25 μl PBS and 25 μl 4x loading buffer and heated at 100°C for 10min. Supernatants
were filter sterilised using a 0.2 μm filter and proteins precipitated with 100% TCA on ice for
45mins and centrifuged at 20,000 g for 5mins at 4°C. Pellets were washed with acetone, heat
dried at 95°C and re-suspended in sterile PBS. Precipitated proteins and cell pellets were quan-
tified using the BCA assay (Thermo Fisher) and equal protein loadings were subjected to
SDS-PAGE andWestern blotting using primaryHcp-1 antibody [17] (1:500) and secondary
anti-rabbit antibody. All were performed in conjunction with the strain SRC1 as a lysis control.
Blots were visualised using Odyssey CLx Infared imaging system.
Co-culture assays using TCBS enumeration plates
Overnight cultures of Vibrio strains were adjusted to OD590 0.03 and grown to OD590 ~1.00,
cultures were then re-adjusted to OD590 0.8. Attacker and prey strains were then mixed at a
ratio of 3 mls: 1 mls respectively. 200 ml of these mixed cultures were then incubated at 30°C
for 5 hours on LB plates to allow contact dependent-killing in triplicate. Following incubation,
co-cultures were harvested from the plates and re-suspended in 1 ml of sterile PBS for enumer-
ation. 10-fold serial dilutions of these suspensions were prepared and 10 μl of each dilution was
spotted onto TCBS agar plates in triplicate. These enumeration plates were then incubated at
37°C overnight. The average cfu/ml was recorded for each triplicate dilution.
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Co-culture assays using selective antibiotic enumeration plates
Assays were performed as described above with the followingmodifications: prey and attacker
strains were grown overnight in LB containing chloramphenicol (10mg/ml) and trimethoprim
(100 mg/ml) respectively. Prior to mixing of the prey and attacker strains, overnight cultures
were centrifuged and re-suspended in fresh LB media containing no antibiotic to prevent kill-
ing due to the antibiotics. Co-cultures using V. fluvialisNCTC 11327 as prey were incubated
on LB plates at 30°C for five hours and co-cultures using V. vulnificusMO6-24/O as prey were
incubated on LB plates at 30°C for two hours. Following incubation to determine T6SS depen-
dent killing, co-cultures were harvested from the plates and re-suspended in 1 ml of sterile PBS
for enumeration. 10-fold serial dilutions of these suspensions were prepared and 10 μl of each
dilution was spotted in triplicate onto LB agar plates that contained trimethoprim and onto
another set of LB plates containing chloramphenicol. These enumeration plates were then
incubated at 37°C overnight. The average cfu/ml was recorded for each triplicate dilution.
G. mellonella infection assay
G.mellonella weighing between 2.0 and 3.0 g were injected in the upper most right proleg with
V. vulnificus cells that had been grown overnight at 37°C in LB using a 25 μl Hamilton Microli-
tre™ syringe 800 series with removable needle (Sigma). Overnight bacterial cultures were
adjusted to ~ 1x107 cfu/ ml (equating to ~ 1x105 cfu/10 μl). Enuermation of the infective dose
was also performed to ensure the correct bacterial input. Infected larvae were then incubated at
37°C and monitored for signs of infection, death was recorded when larvae failed to respond to
touch.
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